Heron Therapeutics
HRTX
#8256
Rank
$0.24 B
Marketcap
$1.31
Share price
0.00%
Change (1 day)
-19.14%
Change (1 year)

Heron Therapeutics (HRTX) - Net assets

Net assets on the balance sheet as of September 2025 : $14.88 Million USD

According to Heron Therapeutics's latest financial reports the company has $14.88 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Heron Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-$33.66 Million-0.95%
2023-12-31$-$33.98 Million-350.32%
2022-12-31$$13.57 M-82.5%
2021-12-31$$77.57 M-67.2%
2020-12-31$$0.23 B-41.44%
2019-12-31$$0.40 B9.1%
2018-12-31$$0.37 B182.27%
2017-12-31$$0.13 B-717.08%
2016-12-31$-$21.26 Million-117.99%
2015-12-31$$0.11 B87.29%
2014-12-31$$63.06 M-8.53%
2013-12-31$$68.94 M33.05%
2012-12-31$$51.81 M228.96%
2011-12-31$$15.75 M1096.96%
2010-12-31$$1.31 M-80.64%
2009-12-31$$6.79 M-10.56%
2008-12-31$$7.59 M-74.22%
2007-12-31$$29.47 M144.41%
2006-12-31$$12.05 M94.41%
2005-12-31$$6.2 M-56.17%
2004-12-31$$14.15 M25.67%
2003-12-31$$11.26 M-27.14%
2002-12-31$$15.45 M-19.36%
2001-12-31$$19.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Alkermes
ALKS
$1.73 B 11,545.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
$0.72 B 4,785.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
$85.08 M 471.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.95 B 6,283.41%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
$0.11 B 647.79%๐Ÿ‡บ๐Ÿ‡ธ USA